Elizabeth H.z. Thompson, EVP, Head of Research & Development at ACADIA PHARMACEUTICALS INC (ACAD), sold 3,435 shares at $21.47 ($74K) on 2026-03-25, disclosed to the SEC on 2026-03-26.
Scheduled sale ($74k) by EVP, Head of Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| HZNP | SELL | 2022-07-11 | $7K | — | Filing → |
| HZNP | SELL | 2022-04-20 | $1.9M | — | Filing → |
| HZNP | SELL | 2021-08-06 | $1.6M | — | Filing → |